Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
9,283
Total Claims
$654K
Drug Cost
691
Beneficiaries
$947
Cost/Patient
Risk Score Breakdown 9/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
-70%
Opioid rate vs peers
0.8% vs 2.6% avg
-11%
Cost per patient vs peers
$947 vs $1,068 avg
+5%
Brand preference vs peers
9.4% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
0.8%
Opioid Rate
71
Opioid Claims
$646
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 868 claims · $494K
Generic: 8,337 claims · $155K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 125 | $86K |
| Rivaroxaban | 71 | $68K |
| Empagliflozin | 61 | $55K |
| Empagliflozin/Linagliptin | 27 | $28K |
| Sitagliptin Phosphate | 19 | $26K |
| Fluticasone/Umeclidin/Vilanter | 29 | $26K |
| Insulin Degludec | 32 | $20K |
| Insulin Aspart | 17 | $15K |
| Mirabegron | 14 | $15K |
| Fluticasone/Vilanterol | 30 | $14K |
| Insulin Glargine,hum.Rec.Anlog | 15 | $12K |
| Insulin Degludec | 23 | $12K |
| Rosuvastatin Calcium | 398 | $12K |
| Insulin Lispro | 15 | $12K |
| Ezetimibe | 94 | $9,497 |
Prescribing Profile
Patient Profile
73
Avg Age
42%
Female
0.89
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About